Our findings highlight a compelling link between circulating bile acids and immune modulation, as GCDCA was shown to promote monocyte differentiation into CD163+ tumor-associated macrophages, which exhibit pro-tumorigenic properties. The gene discussed is CD163; the disease is neoplasm.